Uptake Mechanism of Pitavastatin, a New Inhibitor of HMG-CoA Reductase, in Rat Hepatocytes

スポンサーリンク

概要

論文の詳細を見る
2003-10-30

著者

関連論文

Myelodysplastic Syndrome Complicated by Central Diabetes Insipidus and Cerebral Salt Wasting Syndrome with Peculiar Change in Magnetic Resonance Images
Evidence for Abundant Presence of Chymase-Positive Mast Cells in the Kidneys of Patients with Immunoglobulin A Nephropathy : Effect of Combination Therapy with Prednisolone and Angiotensin II Receptor Blocker Valsartan
Nephrogenic diabetes insipidus due to hydronephrosis in a patient with a solitary kidney
Tubulointerstitial nephritis and uveitis (TINU) syndrome caused by the Chinese herb "Goreisan"
Reversible posterior leukoencephalopathy syndrome : a possible manifestation of Wegener's granulomatosis-mediated endothelial injury
A case of Wegener's granulomatosis associated with progressive dysphagia owing to esophageal involvement
Blunted Response of the Renin-Angiotensin System and Nitric Oxide Synthesis Related to Sodium Sensitivity in Immunoglobulin A Nephropathy
Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase (4) : Interspecies Variation in Laboratory Animals and Humans
Kinetics of Granule Growth in Fluidized Bed Granulation with Moisture Control
Effect of Biliary Excretion on the Pharmacokinetics of Pitavastatin (NK-104) in Dogs
Uptake Mechanism of Pitavastatin, a New Inhibitor of HMG-CoA Reductase, in Rat Hepatocytes
Metabolic Fate of Pitavastatin, a New Inhibitor of HMG-CoA Reductase : Effect of cMOAT Deficiency on Hepatobiliary Excretion in Rats and of mdr1a/b Gene Disruption on Tissue Distribution in Mice
Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reduetase (5) : In Vitro Metabolism and Plasma Protein Binding in Animals and Human
Simultaneous determination of NK-104 and its lactone in biological samples by column-switching high-performance liquid chromatography with ultraviolet detection
Identification of Metabolites of NK-104,an HMG-CoA Reductase Inhibitor, in Rat, Rabbit and Dog Bile
A Fast Projection Algorithm for Adaptive Filtering
Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase (2) : Absorption, Distribution, Metabolism, Excretion and Accumulation Following Repeated Oral Administration of ^C-NK-104 in Rats
Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase (1) : Absorption, Distribution, Metabolism and Excretion in Rats
PHARMACOKINETICS OF NIPRADILOL (K-351), A NEW ANTIHYPERTENSIVE AGENT. I. STUDIES ON INTERSPECIES VARIATION IN LABORATORY ANIMALS
PHARMACOKINETICS OF NIPRADILOL (K-351), A NEW ANTIHYPERTENSIVE AGENT. II. INFLUENCE OF THE ROUTE OF ADMINISTRATION ON BIOAVAILABILITY IN DOGS
Multifocal Fibrosclerosis Combined with Idiopathic Retro-peritoneal and Pericardial Fibrosis
Studies on metabolic fate of pitavastatin (NK-104), a new inhibitor of HMG-CoA reductase-Does glucronidation mediate the lactonization of pitavastatin?
Simultaneous determination of taxol and its metabolites in microsomal samples by a simple thin-layer chromatography radioactivity assay-inhibitory effect of NK-104, a new inhibitor of HMG-CoA reductase
Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase (3) : Foeto-placental Transfer and Mammary Excretion after Oral Administration in Rats
Mathematical Model in the Kinetics of Agitation Fluidized Bed Granulation. Effects of MOisture Content, Damping Speed and Operation Time on Granule Growth Rate
COMPUTER SIMULATION OF AGITATION FLUIDIZED BED GRANULATION BY A TWO-DIMENSIONAL RANDOM ADDITION MODEL
Pharmacokinetics of nipradilol (K-351), a new antihypertensive agent, in human.

もっと見る

スポンサーリンク